Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $5.42 billion. The enterprise value is $5.33 billion.
Important Dates
The last earnings date was Monday, May 5, 2025, before market open.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 49.24 million shares outstanding. The number of shares has increased by 4.08% in one year.
| Current Share Class | 49.24M |
| Shares Outstanding | 49.24M |
| Shares Change (YoY) | +4.08% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 72.43% |
| Float | 37.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.31 |
| Forward PS | 7.72 |
| PB Ratio | 101.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 3.97.
| Current Ratio | 2.03 |
| Quick Ratio | 1.90 |
| Debt / Equity | 3.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.21 |
Financial Efficiency
Return on equity (ROE) is -282.16% and return on invested capital (ROIC) is -50.01%.
| Return on Equity (ROE) | -282.16% |
| Return on Assets (ROA) | -26.18% |
| Return on Invested Capital (ROIC) | -50.01% |
| Return on Capital Employed (ROCE) | -67.81% |
| Revenue Per Employee | $632,734 |
| Profits Per Employee | -$407,426 |
| Employee Count | 683 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 2.31 |
Taxes
In the past 12 months, AXSM has paid $85,000 in taxes.
| Income Tax | 85,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.95% in the last 52 weeks. The beta is 0.45, so AXSM's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +51.95% |
| 50-Day Moving Average | 113.19 |
| 200-Day Moving Average | 99.87 |
| Relative Strength Index (RSI) | 50.92 |
| Average Volume (20 Days) | 651,770 |
Short Selling Information
The latest short interest is 4.20 million, so 8.52% of the outstanding shares have been sold short.
| Short Interest | 4.20M |
| Short Previous Month | 4.42M |
| Short % of Shares Out | 8.52% |
| Short % of Float | 11.29% |
| Short Ratio (days to cover) | 5.17 |
Income Statement
In the last 12 months, AXSM had revenue of $432.16 million and -$278.27 million in losses. Loss per share was -$5.77.
| Revenue | 432.16M |
| Gross Profit | 395.36M |
| Operating Income | -239.22M |
| Pretax Income | -309.56M |
| Net Income | -278.27M |
| EBITDA | -230.96M |
| EBIT | -239.22M |
| Loss Per Share | -$5.77 |
Full Income StatementBalance Sheet
The company has $300.91 million in cash and $211.23 million in debt, giving a net cash position of $89.68 million or $1.82 per share.
| Cash & Cash Equivalents | 300.91M |
| Total Debt | 211.23M |
| Net Cash | 89.68M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 53.21M |
| Book Value Per Share | 1.08 |
| Working Capital | 250.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$118.32 million and capital expenditures -$510,000, giving a free cash flow of -$118.83 million.
| Operating Cash Flow | -118.32M |
| Capital Expenditures | -510,000 |
| Free Cash Flow | -118.83M |
| FCF Per Share | -$2.41 |
Full Cash Flow StatementMargins
Gross margin is 91.49%, with operating and profit margins of -55.36% and -64.39%.
| Gross Margin | 91.49% |
| Operating Margin | -55.36% |
| Pretax Margin | -64.37% |
| Profit Margin | -64.39% |
| EBITDA Margin | -53.44% |
| EBIT Margin | -55.36% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.08% |
| Shareholder Yield | -4.08% |
| Earnings Yield | -5.13% |
| FCF Yield | -2.19% |
Dividend DetailsAnalyst Forecast
The average price target for AXSM is $170.20, which is 54.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $170.20 |
| Price Target Difference | 54.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 47.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 1.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.99 |
| Piotroski F-Score | 3 |